Quick 'sponge on a string' test for oesophageal cancer could be offered at local surgeries, NICE says
Draft guidance recommends capsule sponge tests for people with persistent acid reflux, easing pressure on hospital endoscopy across England.
People with persistent acid reflux could soon be offered a quick "sponge on a string" test at their local surgery or community diagnostic centre to check for early signs of oesophageal cancer, instead of waiting for a hospital camera examination, under draft guidance published today by NICE.
The National Institute for Health and Care Excellence has recommended two capsule sponge tests, Cytosponge and EndoSign, to help detect oesophageal cancer and Barrett's oesophagus in people with long-term gastro-oesophageal reflux disease, commonly known as acid reflux. The draft guidance is now open for consultation, with final recommendations due in the new year.
How the test works
The patient swallows a small capsule attached to a thread. The capsule dissolves in the stomach, letting the sponge inside expand, which takes about seven minutes. A healthcare professional then gently pulls the sponge back up, and as it passes through the oesophagus, or food pipe, it collects cells from the lining. The sample goes to a laboratory to be checked for changes linked to cancer or Barrett's oesophagus.
The test needs no sedation, and anyone whose result suggests possible cancer or Barrett's oesophagus is referred for an endoscopy to confirm the findings.
Why it matters
Barrett's oesophagus, in which cells lining the lower food pipe change, affects an estimated 1 to 2% of adults and is more common in people with long-term reflux. It raises the risk of oesophageal cancer, although most people with it never develop cancer. Oesophageal cancer is much harder to treat when found late, so earlier detection matters.
Demand for NHS endoscopy is high, and NICE says some people with Barrett's oesophagus are not being checked as often as guidance recommends. The sponge tests could also be used to monitor people already diagnosed.
Professor Jonathan Benger, chief executive of NICE, said: "Capsule sponge tests offer a quick and less invasive way to detect concerning changes associated with oesophageal cancer or Barrett's oesophagus, helping to identify people who should go on to have further tests and treatment."
Professor Peter Johnson, national clinical director for cancer at NHS England, said thousands had already benefited through NHS pilots. "Many people have acid reflux, and having an easier way to check for changes in the lining of the oesophagus can make a big difference for patients," he said.
Available wherever you live
The recommendations are the first produced through the new National HealthTech Access Programme, part of the government's 10 Year Health Plan. If a technology is recommended in final guidance, it should be funded by the NHS and available to eligible patients across England, rather than depending on where they live.
NICE stresses that no test, including endoscopy, catches every case, and people given an all-clear should still be monitored over the long term. Anyone with heartburn or reflux that keeps coming back should speak to their GP.
More in Health
All
Latest news
-
16 Nov
New direct Birmingham to Crewe trains start on 13 December, the first step to a Manchester Airport link
-
16 Nov
Apple launches study of 200,000 people to test how useful AI answers to health questions really are
-
16 Nov
Asian Business Chamber's Diwali celebration at St Andrew's explores innovation, from cybersecurity to football
Featured posts
-
Things to do
Top 10 places to visit in Birmingham
-
Food and drink
The 12 most popular food spots in Birmingham
-
Things to do
The best laser tag locations in Birmingham